The transcriptional cascade associated with creatine kinase down-regulation and mitochondrial biogenesis in mice

Soumen Bera1, Manju Ray

  • 1Department of Biological Chemistry, Indian Association for the Cultivation of Science, Jadavpur, Kolkata, 700 032, India. bcsb@iacs.res.in

Insights

Muscle degeneration in sarcoma causes creatine kinase (CK) down-regulation. This study reveals TNF-alpha activation, nitric oxide production, and stimulated mitochondrial biogenesis, indicating altered cellular energy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Tissue-specific creatine kinase (CK) isoforms are regulated by transcription factors like MyoD and MEF2.
  • Tumor necrosis factor-alpha (TNF-alpha) can degrade MyoD and myogenin mRNA, leading to muscle wasting and reduced muscle-type CK (MCK) expression.
  • Previous studies showed a complete loss of CK activity in sarcoma-induced mouse skeletal muscle.

Purpose of the Study:

  • Investigate the transcriptional regulation of CK down-regulation in carcinogen-induced mouse muscle sarcoma.
  • Explore the activation of mitochondrial biogenesis in sarcoma, considering the link between CK deficiency, nitric oxide synthase (NOS) overexpression, and mitochondrial biogenesis.

Main Methods:

  • Induced sarcoma in mouse skeletal muscle.
  • Analyzed transcriptional changes related to CK expression and mitochondrial biogenesis.
  • Measured enzyme activities (e.g., cytochrome c oxidase) and molecular markers (e.g., DNA content, mRNA levels).

Main Results:

  • Observed activation of the TNF-alpha pathway, leading to nitric oxide production and NFkappaB activation.
  • Confirmed degradation of MyoD and myogenin mRNA.
  • Found increased cytochrome c oxidase activity and mitochondrial DNA content in sarcoma.
  • Identified a role for PGC-related co-activators in upregulating nuclear respiratory factors and mitochondrial transcription factor A, driving mitochondrial biogenesis.

Conclusions:

  • Severe muscle degeneration in sarcoma results in creatine kinase (CK) down-regulation.
  • Stimulated mitochondrial biogenesis occurs alongside CK deficiency and NOS overexpression.
  • The findings suggest an altered bioenergetic profile in sarcoma-affected muscle tissue.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...